Crowdonomics
This isn’t TURN THERAPEUTICS’s most recent raise. Reg A+ · Equity · Jan 2025 (Closed) is more current.View latest round
TURN THERAPEUTICS

Reg CF · Common Stock · Oct 2024

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$955.5K / $4.1M max
23% of ceiling · target hit day 4
Investors
700
$3.3K avg
Post-money valuation
$125.9M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$2.3M$1.2M$0
7023510
Oct 28, 2024 · openedOct 22, 2025 · last reading
Target ($15K) hit — Nov 1, 2024, day 4$1.0M raised — Nov 22, 2024Deadline Mar 15, 2025

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$0
−$4.3M
FY2022
$0
−$2.3M
FY2023
RevenueNet income
Metric
FY2022 audited
FY2023 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$4,286,851
-$2,292,267
Taxes paid
$0
$0
Balance sheet
Cash
$2,102,983
$1,180,997
Accounts receivable
$0
$0
Total assets
$2,913,411
$2,013,560
Short-term debt
$1,724,014
$0
Long-term debt
$34,203
$0
Total liabilities
$1,758,217
$1,927,792
Other
Headcount
—
1

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

2 amendments
  1. Jan 17, 2025
    • Deadline Jan 20, 2025 → Mar 15, 2025

    “Issuer is extending their campaign end date to March 15th, 2025.”

    Form C/A on EDGAR ↗
  2. Dec 18, 2024
    No change to filed terms

    “Issuer is updating their campaign page.”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$123.6M
Post-money$125.9M
Price / share$9.18
Price / share today$4.59
Shares offered1,633

$9.18 as sold; $4.59 after the Sep 2025 split (2:1) (Form 10-Q, p. 1).

Perks

Invest 5,000+ and receive 3% bonus shares3% bonus

Offering details

Target$14,991
Max$4,073,698
Min investment$248
OpenedOct 28, 2024
DeadlineMar 15, 2025
Days active712

Links & provenance

Source: Manual
0001665160-24-001439
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.